Cargando…
Zoledronic Acid–Induced Interface Dermatitis
Zoledronic acid (ZA) is a bisphosphonate given intravenously, most commonly for the treatment of postmenopausal osteoporosis. Increase in usage of ZA because it was FDA-approved has resulted in increasing reports of side effects. For the most part, these are systemic. Cutaneous side effects associat...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The American Journal of Dermatopathology
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4894795/ https://www.ncbi.nlm.nih.gov/pubmed/26588338 http://dx.doi.org/10.1097/DAD.0000000000000341 |